Advertisement

Inpharma Weekly

, Volume 1189, Issue 1, pp 3–4 | Cite as

Ethical considerations in the coverage of ‘lifestyle’ drugs

  • Dilesh Doshi
Newsletter Article
  • 3 Downloads

Abstract

One of the most difficult challenges that policy-makers will face in the next 10 years is tackling the ethical considerations involved in the coverage of so-called ‘lifestyle’ drugs. Should health plans provide coverage for such drugs? If so, should limits be set? And will limits jeopardise physician-patient relationships? At the sixth annual Drug Information Association symposium on Quality of Life Evaluation [ Hilton Head, South Carolina, US; March 1999 ], Dr James Sabin shared his experience in establishing coverage policies and provided some answers to these questions. *

Keywords

Health Plan Public Disclosure Drug Coverage Coverage Policy Harvard Pilgrim Health 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Copyright information

© Adis International Ltd 1999

Authors and Affiliations

  • Dilesh Doshi

There are no affiliations available

Personalised recommendations